Published Aug 24, 2026
Emergent BioSolutions (NYSE: EBS, CIK 0001367644): A Biodefense Pivot Built Around an Opioid Writedown
In-depth research on EBS covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
6,091 words27 min read
Read report